Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jeff Kapler"'
Autor:
Conar R O’Neil, Jack XQ Pang, Samuel S Lee, Mark G Swain, Kelly W Burak, Patricia Klein, Robert P Myers, Jeff Kapler, Michael J Gill, Martin Labrie, Carla S Coffin
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 26, Iss 6, Pp 293-296 (2015)
Externí odkaz:
https://doaj.org/article/6866c45343744c55949669fe9ac83773
Autor:
Jeff Kapler, Meredith A. Borman, Oscar E Larios, Abdel A. Shaheen, Gisela Macphail, Golasa S Kochaksaraei, Samuel S. Lee, Carla S Coffin, Mark G Swain, Breean Haslam, Alex Aspinall, Kelly W Burak
Background High hepatitis C cure rates have been observed in registration trials with second-generation direct-acting antivirals. Real-world data also indicate high sustained viral response (SVR) rates. Our objective was to determine real-world SVR r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b30c717e714a9a17695bd21b7678e9
https://europepmc.org/articles/PMC5963434/
https://europepmc.org/articles/PMC5963434/
Publikováno v:
The Canadian journal of hospital pharmacy. 66(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22d6726d689b749c79fc28bd45f5fab7
https://pubmed.ncbi.nlm.nih.gov/23616677
https://pubmed.ncbi.nlm.nih.gov/23616677
Publikováno v:
The Canadian Journal of Hospital Pharmacy. 66
Rivaroxaban is a selective, reversible inhibitor of factor Xa that is used for the prevention and treatment of venous thromboembolism (VTE) and for the prevention of stroke in patients with atrial fibrillation. Nevirapine is a non-nucleoside reverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7df01e90d8aadbd19a6ef82b5476053b
https://doi.org/10.4212/cjhp.v66i2.1235
https://doi.org/10.4212/cjhp.v66i2.1235
Autor:
Natalie Dayneka, Jeff Kapler, Alice Tseng, Niamh Higgins, Nancy L. Sheehan, Carlo Quaia, Shannon Stone, Shanna Chan, Deborah V. Kelly, Michelle Foisy, Christine A. Hughes, Linda Robinson, Charles J L la Porte, Deborah Yoong, Pam Nickel, Laura Y. Park-Wyllie, Pierre Giguère, Linda Sulz, Cara Hills-Nieminen
Publikováno v:
Scopus-Elsevier
Over the past decade, there have been numerous advances in HIV therapy, with 6 drug classes comprising 24 indivi dual antiretroviral agents now available. For patients who are adherent with therapy and who have an undetectable viral load, HIV has bec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f13d6ace91f4668b9352a6a0b958ff
https://europepmc.org/articles/PMC3329905/
https://europepmc.org/articles/PMC3329905/